Reporter Looking for a Patient to Interview

I recently gave an interview to Jo Cavallo, a journalist who is writing a story for a national medical magazine about the dilemma of paying for new targeted therapies against cancer. She asked that I post the following request for interview:

Interview Request

I'm writing a magazine story about the high cost of targeted cancer drugs and I'm looking for cancer patients to interview who have either refused treatment because they can't afford their insurance co-payment
or don't have health insurance at all and can't get the drugs. If you're interested in being interviewed, please e-mail me at jcava15579@aol.com.

If you know of a patient who has had such difficulty please email Ms. Cavallo. Thanks.

More like this

Via my colleague, PharmCanuck, comes news of an in-depth radio program on dichloroacetate (DCA) that aired this past Tuesday on CBC's, "The Current." As a reminder to readers who aren't already bored senseless of my discussion of this chemical, DCA is a small molecule freely-available in the…
Except this time it's from the right! Richard Dolinar of the Heartland Institute (a crank tank) writes in TCS Daily that evidence-based medicine (EBM) is bad for patients. A new buzzword entered the medical lexicon in 1992 when the Evidence-Based Medicine Working Group published one of the first…
While we take a breather during this holiday season, we’re re-posting content from earlier in the year. This post was originally published on January 6, 2014. by Liz Borkowski, MPH Now that it’s 2014, millions more people in the US have health insurance coverage (either Medicaid or private…
Now that it’s 2014, millions more people in the US have health insurance coverage (either Medicaid or private insurance), thanks to the Affordable Care Act. In the weeks ahead, many of the newly insured will be visiting healthcare providers to address ongoing health concerns. The Washington Post’s…

I suggest looking at The Wall Street Journal's "The Most Expensive Drugs" series (late 2005 to early 2006). These articles featured several patients who were refusing treatment because of the extraordinarily high cost of treatment.